News Universe Pharmaceuticals INC

Equities

UPC

KYG9442G1120

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-03 pm EDT			5-day change	1st Jan Change
2.15 ^USD	-0.92%		-1.38%	+6.97%

Apr. 15	Top Premarket Decliners	MT
Jan. 30	Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Top Premarket Decliners	Apr. 15	MT
Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results	Jan. 30	PR
Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2023	Jan. 30	CI
Top Premarket Gainers	23-09-11	MT
Universe Pharmaceuticals INC Reports Earnings Results for the Half Year Ended March 31, 2023	23-08-31	CI
Universe Pharmaceuticals : Receipt of Nasdaq Notification Regarding Compliance with Nasdaq Minimum Bid Price Requirement - Form 6-K	23-08-16	PU
Universe Pharmaceuticals Receives Nasdaq Non-Compliance Notice	23-08-04	MT
Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares	23-08-04	AQ
Universe Pharmaceuticals INC Announces Share Consolidation	23-07-27	AQ
Universe Pharmaceuticals : Results of the Universe Pharmaceuticals INC 2023 Annual General Meeting - Form 6-K	23-07-05	PU
Universe Pharmaceuticals INC Announces Board Changes	23-05-05	CI
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	23-03-07	AQ
Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2022	23-02-10	CI
Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19	22-12-21	AQ
Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19	22-12-21	CI
Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement	22-11-14	GL
Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement	22-11-14	AQ
Universe Pharmaceuticals : Results of the Universe Pharmaceuticals INC 2022 Annual General Meeting - Form 6-K	22-09-28	PU
Universe Pharmaceuticals INC Reports Earnings Results for the Half Year Ended March 31, 2022	22-08-16	CI
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022	22-08-16	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Universe Pharmaceuticals INC

Equities

UPC

KYG9442G1120

Summary

Filters